Hot Features
プレミアム
Iovance Biotherapeutics Inc (IOVA)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | Mr. Daniel G. KirbyChief Commercial Officer | -2.44k | 9.01k | Derivative Exercise and Sale | 3.70 | 146.95k | - |
| 2026-05-11 | Mr. Daniel G. KirbyChief Commercial Officer | 7.57k | 0.00 | Derivative Exercise and Retained Stock | - | 146.95k | 5.43% |
| 2026-03-05 | Dr. Friedrich Graf FinckensteinChief Medical Officer | 14.73k | 0.00 | Derivative Exercise and Retained Stock | - | 131.96k | 12.56% |
| 2026-03-05 | Dr. Friedrich Graf FinckensteinChief Medical Officer | -16.52k | 75.66k | Derivative Exercise and Sale | 4.58 | 131.96k | - |
| 2026-03-05 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | 35.74k | 0.00 | Derivative Exercise and Retained Stock | - | 529.54k | 7.24% |
| 2026-03-05 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | -26.76k | 122.54k | Derivative Exercise and Sale | 4.58 | 529.54k | - |
| 2026-03-05 | Dr. Raj K. PuriChief Regulatory Officer | 20.70k | 0.00 | Derivative Exercise and Retained Stock | - | 239.23k | 9.47% |
| 2026-03-05 | Dr. Raj K. PuriChief Regulatory Officer | -18.36k | 84.09k | Derivative Exercise and Sale | 4.58 | 239.23k | - |
| 2026-03-05 | Dr. Igor P. BilinskyCOO | 14.62k | 0.00 | Derivative Exercise and Retained Stock | - | 125.77k | 13.15% |
| 2026-03-05 | Dr. Igor P. BilinskyCOO | -16.63k | 76.16k | Derivative Exercise and Sale | 4.58 | 125.77k | - |
| 2026-03-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | 29.28k | 0.00 | Derivative Exercise and Retained Stock | - | 493.80k | 6.30% |
| 2026-03-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | -22.81k | 86.45k | Derivative Exercise and Sale | 3.79 | 493.80k | - |
| 2026-03-02 | Dr. Raj K. PuriChief Regulatory Officer | 2.67k | 0.00 | Derivative Exercise and Retained Stock | - | 218.53k | 1.24% |
| 2026-03-02 | Dr. Raj K. PuriChief Regulatory Officer | -2.80k | 10.60k | Derivative Exercise and Sale | 3.79 | 218.53k | - |
| 2026-03-02 | Dr. Igor P. BilinskyCOO | 5.40k | 0.00 | Derivative Exercise and Retained Stock | - | 111.15k | 5.11% |
| 2026-03-02 | Dr. Igor P. BilinskyCOO | -6.90k | 26.16k | Derivative Exercise and Sale | 3.79 | 111.15k | - |
| 2026-03-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | 5.58k | 0.00 | Derivative Exercise and Retained Stock | - | 117.23k | 4.99% |
| 2026-03-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | -7.12k | 26.99k | Derivative Exercise and Sale | 3.79 | 117.23k | - |
| 2026-02-24 | Mr. Daniel G. KirbyChief Commercial Officer | 85.84k | 0.00 | Derivative Exercise and Retained Stock | - | 139.38k | 160.30% |
| 2026-02-24 | Mr. Daniel G. KirbyChief Commercial Officer | -34.17k | 129.14k | Derivative Exercise and Sale | 3.78 | 139.38k | - |
| 2026-02-10 | Mr. Daniel G. KirbyChief Commercial Officer | 23.55k | 0.00 | Derivative Exercise and Retained Stock | - | 53.55k | 78.49% |
| 2026-02-10 | Mr. Daniel G. KirbyChief Commercial Officer | -16.45k | 42.77k | Derivative Exercise and Sale | 2.60 | 53.55k | - |
| 2025-12-01 | Dr. Friedrich Graf FinckensteinChief Medical Officer | 6.25k | 0.00 | Derivative Exercise and Retained Stock | - | 111.66k | 5.93% |
| 2025-12-01 | Dr. Friedrich Graf FinckensteinChief Medical Officer | -6.45k | 14.20k | Derivative Exercise and Sale | 2.14 - 2.23 | 111.66k | - |
| 2025-12-01 | Dr. Igor P. BilinskyCOO | 6.06k | 0.00 | Derivative Exercise and Retained Stock | - | 105.74k | 6.07% |
| 2025-12-01 | Dr. Igor P. BilinskyCOO | -6.25k | 13.78k | Derivative Exercise and Sale | 2.14 - 2.23 | 105.74k | - |
| 2025-12-01 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | 29.96k | 0.00 | Derivative Exercise and Retained Stock | - | 464.52k | 6.89% |
| 2025-12-01 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | -22.13k | 48.94k | Derivative Exercise and Sale | 2.14 - 2.23 | 464.52k | - |
| 2025-12-01 | Dr. Raj K. PuriChief Regulatory Officer | 3.00k | 0.00 | Derivative Exercise and Retained Stock | - | 215.86k | 1.41% |
| 2025-12-01 | Dr. Raj K. PuriChief Regulatory Officer | -2.47k | 5.50k | Derivative Exercise and Sale | 2.23 | 215.86k | - |
| 2025-09-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | 29.96k | 0.00 | Derivative Exercise and Retained Stock | - | 434.56k | 7.40% |
| 2025-09-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | -22.13k | 48.46k | Derivative Exercise and Sale | 2.19 | 434.56k | - |
| 2025-09-02 | Dr. Raj K. PuriChief Regulatory Officer | 3.00k | 0.00 | Derivative Exercise and Retained Stock | - | 212.86k | 1.43% |
| 2025-09-02 | Dr. Raj K. PuriChief Regulatory Officer | -2.47k | 5.40k | Derivative Exercise and Sale | 2.19 | 212.86k | - |
| 2025-09-02 | Dr. Igor P. BilinskyCOO | 6.06k | 0.00 | Derivative Exercise and Retained Stock | - | 99.69k | 6.47% |
| 2025-09-02 | Dr. Igor P. BilinskyCOO | -6.25k | 13.69k | Derivative Exercise and Sale | 2.19 | 99.69k | - |
| 2025-09-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | 6.25k | 0.00 | Derivative Exercise and Retained Stock | - | 105.41k | 6.30% |
| 2025-09-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | -6.45k | 14.12k | Derivative Exercise and Sale | 2.19 | 105.41k | - |
| 2025-06-05 | Mr. Daniel G. KirbyChief Commercial Officer | 30.00k | 55.20k | 買い | 1.84 | 30.00k | - |
| 2025-06-02 | Dr. Raj K. PuriChief Regulatory Officer | 3.00k | 0.00 | Derivative Exercise and Retained Stock | - | 209.85k | 1.45% |
| 2025-06-02 | Dr. Raj K. PuriChief Regulatory Officer | -2.47k | 4.34k | Derivative Exercise and Sale | 1.76 | 209.85k | - |
| 2025-06-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | 29.96k | 0.00 | Derivative Exercise and Retained Stock | - | 404.60k | 8.00% |
| 2025-06-02 | Dr. Frederick G. VogtInterim CEO, President, General Counsel, Corporate Secretary & Director | -22.13k | 38.94k | Derivative Exercise and Sale | 1.76 | 404.60k | - |
| 2025-06-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | 6.25k | 0.00 | Derivative Exercise and Retained Stock | - | 99.16k | 6.72% |
| 2025-06-02 | Dr. Friedrich Graf FinckensteinChief Medical Officer | -6.45k | 11.35k | Derivative Exercise and Sale | 1.76 | 99.16k | - |
| 2025-06-02 | Dr. Igor P. BilinskyCOO | 6.06k | 0.00 | Derivative Exercise and Retained Stock | - | 93.63k | 6.91% |
| 2025-06-02 | Dr. Igor P. BilinskyCOO | -6.25k | 11.00k | Derivative Exercise and Sale | 1.76 | 93.63k | - |
| 2025-06-02 | Mr. Jean-Marc Belleminインサイダー | 4.33k | 0.00 | Derivative Exercise and Retained Stock | - | 60.53k | 7.70% |
| 2025-06-02 | Mr. Jean-Marc Belleminインサイダー | -4.46k | 7.86k | Derivative Exercise and Sale | 1.76 | 60.53k | - |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
